Normunity

Developer of immunotherapies for the treatment of cancer

placeBoston, Massachusetts, United States calendar_todayFounded 2020 groups19 employees language normunity.com

Innovation

3 patent families — focus: Chemistry & metallurgy; filing pace active. Cited 13 times.

YearFilings
20252
20261

Social engagement

Social engagement: 2.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Canaan, Samsara BioCapital, Enavate Sciences.

Investor typeCountShare
Venture capital982%
Private equity19%
Other / undisclosed19%

Recent activity

8 Jun 2026
Event
MIT CEO Conference
26 May 2026
Event
8th Annual Emerging Frontiers in Oncology
9 Apr 2026
Leadership hire
Chief Development Officer
Coming soon